The authoritative source for research information and outputs is Elsevier Scopus, with researcher profile verification from the Deanship of Scientific Research.
المخرجات
Research outputs
Articles, reviews, conference papers and book chapters, indexed by DOI and linked to University researchers.
Telehealth adoption gained popularity during the coronavirus disease 2019 (COVID-19) pandemic and had substantial and various impacts on patient outcomes depending on the specific environment, healthcare system, and quality of telehealth services supplied. Hence, this systematic review explored those impacts and their sustainability post-pandemic. To conduct this systematic review, a thorough literature search was undertaken in electronic databases such as PubMed, Medline, Web of Science, Google Scholar, databases, Embase, and PsycINFO using relevant keywords. We included articles written in English and published in the last 10 years that reported on the impact of telehealth adoption on various patient outcomes and the impact of sustainability post-pandemic. The findings of this systematic review highlight the remarkable impact of telehealth adoption on patient outcomes and the sustainability of these initiatives post-pandemic. Telehealth has proven to enhance various aspects of healthcare, spanning from prevention to follow-up. Another effect of telehealth adoption is the significant reduction in hospitalizations. Furthermore, telehealth profoundly impacts hospital stays, leading to a decrease in all-cause hospital days per patient by 1.07 (95% confidence interval (CI): 1.76 to 0.39) days and a shorter mean hospital stay for condition-related hospitalizations by 89% (95% CI 1.42 to 0.36), providing evidence of efficient healthcare delivery. There was also a reduction in mortality rates for patients receiving telemedicine interventions. Telehealth is also cost-effective while remaining highly effective. Patient satisfaction is another key outcome of telehealth adoption observed. The convenience and reduced expenses of telehealth have garnered positive feedback from patients, reinforcing the desirability of telehealth as a viable alternative to in-person visits. Despite these numerous benefits, barriers and disparities in telehealth adoption and utilization persist, especially in rural hospitals that face challenges, including a lack of Health Information Exchange (HIE) capacity, limited patient engagement capabilities, and the absence of financial reimbursement. This systematic review underscores the remarkable impact of telehealth adoption on patient outcomes and its sustainability post-pandemic. However, barriers and disparities still exist, requiring attention to ensure equitable access to telehealth services. The evidence supports the continued development and implementation of telehealth initiatives to improve healthcare delivery and patient outcomes post-pandemic.
Background: The cardiotoxic effects of doxorubicin (DOX), a powerful chemotherapeutic drug, are widely recognized. Cuproptosis, a unique copper-dependent form of controlled cell death, may be involved in DOX-induced cardiomyopathy, according to recent findings. This study employs both in vivo and in silico procedures to investigate the protective effects of the copper chelator penicillamine (PEN) and the role of cuproptosis in DOX-related cardiotoxicity. Methods: Thirty-two adult Sprague Dawley rats were allocated into four groups (n = 8): control, DOX, DOX+PEN, and PEN. Cardiac function was assessed via echocardiography. Serum cardiac biomarkers (LDH, CK-MB, CTnI), oxidative stress markers (SOD, GPX, MDA), and expression levels of cuproptosis-related genes (FDX1, LIAS, SLC31A1, ATP7A) were evaluated. Histopathological examinations and immunohistochemical staining for FDX1, SLC31A1, and DLAT were performed. Molecular docking simulated PEN’s interaction with cuproptosis-related proteins. Network pharmacology and molecular docking studies were also conducted to identify core molecular targets and simulate PEN’s binding interactions with key cuproptosis regulators. Results: DOX administration induced significant cardiac dysfunction, oxidative stress, and upregulation of cuproptosis markers. PEN treatment mitigated these effects, improved cardiac function, reduced fibrosis, and suppressed the expression of cuproptosis-related genes and proteins. Docking results confirmed strong interactions between PEN and cuproptosis-regulatory proteins. Network pharmacology revealed 14 key overlapping targets linking PEN with cuproptosis and DOX-induced cardiotoxicity. Conclusion: This study provides experimental evidence implicating cuproptosis in DOX-induced cardiomyopathy. PEN exerts cardioprotection, potentially by targeting this pathway, offering a promising therapeutic strategy.
ABSTRACT The growing environmental concerns associated with petrochemical‐based plastics, including their persistence, contribution to climate change, and adverse effects on ecosystems and human health, have accelerated the search for sustainable alternatives. Starch‐based bioplastics have emerged as a promising solution due to their biodegradability, renewability, and compatibility with existing food packaging technologies. This review comprehensively examines production mechanisms of starch‐based bioplastics, focusing on their formulation, structural modifications, and industrial applications. The role of plasticizers in improving flexibility and reducing brittleness is discussed. Their natural decomposition into environmentally benign byproducts supports a circular economy and aligns with global sustainability goals. However, the downside of using bioplastic is that the raw material used for its fabrication is also used for sustenance, and so a trade‐off between growing feedstock crops and food production is inevitable. The higher manufacturing costs of bioplastics as compared to conventional plastics are also a limiting factor. Hence, bioplastics do not completely serve as a long‐term panacea for problems associated with plastic pollution. This review therefore attempts to (i) enumerate the benefits of starch in food packaging, (ii) delineate the physical and chemical treatments that enhance hydrophobicity, mechanical strength, and thermal stability, (iii) suggest the proper disposal procedures to ward off health issues and to conserve the environment, and (iv) advocate the implementation of stringent recycling measures and emphasize on the policies and legislation for green transition. Future research should focus on optimizing polymer blends, reinforcing compatibility with synthetic and natural polymers, and advancing manufacturing techniques to enable widespread adoption in food packaging applications.
Systemic lupus erythematosus (SLE) is an autoimmune disorder branded via over-activation of the immune system, resulting in atypical roles of natural and adaptive immune cells and the making of numerous autoantibodies against nuclear components. The causes and pathogenesis of this disease are not completely realized. The gut microbiota plays a significant character in human health and disorder, particularly in autoimmune diseases.Gut microbiome dysbiosis can affect the host immune system as suggested by several recent studies, balance and activity of the gut microbiome, which are influenced by daily diet, might be associated with disease activity in SLE. There are rising signs to support the immunomodulatory abilities of certain probiotics. Numerous investigational and clinical surveys have demonstrated the useful effects of certain probiotic bacteria, mainly strains of Lactobacillus and Bifidobacterium, in patients with SLE. Various species of bacteria were found to be positively or negatively associated with SLE gut microbiomes. A better comprehension of the Studying the gut microbiota will provide a good opportunity to identify microbes involved in tolerance in systemic lupus patients. The purpose of this study is to review the existing literature on probiotics that have the ability to restore tolerance and modulate the levels of inflammatory or anti-inflammatory cytokines that play a role in SLE.
International Journal of Computational Intelligence Systems · vol. 18 (1)
Artificial intelligence (AI) transforms multiple businesses, including medical research, where AI-driven developments bring significant advantages. The application of machine learning algorithms enables medical researchers to examine large amounts of data accurately, which leads to the development of precise and effective treatment approaches. Lung cancer leads the list of critical healthcare issues because it remains the world’s most lethal form of cancer thus demanding innovative diagnostic tools for faster and accurate identification. The proposed study introduces an innovative method called CTGAN-RF which uses conditional tabular generative adversarial networks (CTGAN) and random forest (RF) classifier to detect lung cancer through synthetic data generation. The proposed model demonstrated superior performance by achieving a 0.9893 score of accuracy and 0.99 value for precision, F1 score, and recall. Extensive experimental evaluation for this method included testing nine classification algorithms. The implementation of different classifiers employed data balancing methods including SMOTE and borderline-SMOTE along with SMOTE ENN and unbalanced data configurations. Comparative analysis showed that CTGAN-RF consistently performed significantly better than traditional classifiers in dealing with class imbalance and improving prediction accuracy. After testing with fivefold cross-validation, the reliability of the model was further validated. In comparison to cutting-edge approaches for lung cancer diagnosis, the proposed methodology outperformed in terms of classification metrics. This in-depth evaluation of synthetic data augmentation with machine learning in lung cancer detection has helped in the development of personalized treatment strategies in the fight against such a life-threatening disease.
lung cancer detectionsynthetic data augmentationCTGANrandom forest
EURASIP Journal on Wireless Communications and Networking · vol. 2025 (1)
Abstract Dynamic situations and applications are supported by the diverse devices and communication technologies that constitute the Internet of Things concept. Despite this, communication backlogs are common due to rising network demand and insufficient resource allocation. This study provides a way to fix resource allocation problems using Mutable Resource Allocation and Distributed Federated Learning. Inadequacies and backlogs in resources are identified at the edge of the network. As part of this procedure, edge devices are assigned to link resources and users after independently determining which resources cannot be allocated and which shortcomings are linked with them. Adapting to demand and learning suggestions, this allocation is flexible. By classifying resources as sufficient or inadequate, the learning suggestions help avoid backlogs. This enables edge devices to choose between allocation and response, which improves network flexibility by prioritizing inadequate resource allocation. Accordingly, the recommendation factor periodically affects modifications to the edge connection and its interaction with the Internet of Things platform. The suggestion is particularly strong for situations with changing backlogs to ensure that subsequent resource allocations align with preference-based learning. Claiming to improve connection, services, and resource allocation while decreasing backlogs and allocation times, this approach is a hot commodity.
dynamic resource allocationdecentralized federated learningedge computingInternet of Things
As the global population grows, urbanization depletes water resources and significantly reduces cropland available for agriculture. This study proposes a Big Data Analytics-Integrated Agriculture Resource Management Framework (BDA-ARMF) to optimize resource utilization and enhance farm sustainability. The integration of BDA in agriculture offers substantial advantages, including improved management of consumer demand, enhanced farm operations, sustainable food production and better alignment of supply with demand. The framework combines BDA with the Internet of Things and cloud computing to improve accuracy, intelligence and sustainability in agriculture. Efficient data-driven farming requires actionable insights to minimize resource waste and environmental contamination. The proposed model outperforms previous approaches, delivering significant improvements in water management (97.8%), prediction accuracy (97.6%), production efficiency (96.4%), resource consumption reduction (11.5%) and risk assessment enhancement (94.7%). The proposed framework reduces resource waste and mitigates environmental impact, enabling sustainable agricultural systems and efficient, data-driven farming practices.
big data analyticsagricultural resource managementsustainable agriculturewater management
BACKGROUND: Primary osteoblasts are essential for bone formation and regeneration, making them pivotal in dental applications, including periodontal regeneration, ridge augmentation, and implant osseointegration. Sourced from various tissues like alveolar bone, calvarial bone, mandibular and maxillary bones, long bones, and bone marrow-derived stem cells (BMSCs), each type of osteoblast presents unique advantages and limitations related to yield, accessibility, and clinical relevance. Given these variables, selecting an appropriate source is crucial for experimental consistency and translational application in dentistry. METHODS: This review synthesizes data from in vitro, animal, and clinical studies to provide a comprehensive overview of osteoblast sourcing, isolation, and characterization in dental research. Sources were reviewed based on yield, anatomical relevance, and accessibility, while isolation methods were compared to assess their impact on cell behavior and phenotype retention. The review evaluates methods such as enzymatic digestion, explant culture, and differentiation of BMSCs, alongside characterization techniques like morphological analysis, gene expression profiling, and mineralization assays. RESULTS: The analysis shows that alveolar bone-derived osteoblasts offer high clinical relevance due to their anatomical similarity to oral structures but are limited by low yield and invasive collection. Calvarial and long bone osteoblasts provide higher yields, making them useful for material testing, though they lack biomechanical compatibility with oral environments. BMSCs offer a renewable source with significant regenerative potential but require precise differentiation protocols. In vitro studies contribute mechanistic insights, while animal models bridge the gap to clinical application, despite challenges in standardization and interspecies variability. CONCLUSION: This review highlights the importance of selecting appropriate osteoblast sources and methods for dental research to optimize outcomes in periodontal and implant-related therapies. The variability across study designs and experimental outcomes underscores the need for standardized protocols and targeted systematic reviews within specific research settings. These findings offer a framework for future osteoblast-based research and guide the effective translation of osteoblast therapies into clinical dental practice.
osteoblast isolationdental tissue regenerationbone marrow-derived stem cellsalveolar bone
This study demonstrates the green synthesis, characterization, and biomedical applications of zinc oxide nanoparticles (ZnONPs) using Zingiber officinale (Z. officinale) (ginger) peel extract. Green synthesis offers advantages over conventional methods, including environmental friendliness, cost-effectiveness, and enhanced biocompatibility. Ultraviolet-Visible (UV-Vis) spectroscopy confirmed ZnONPs formation with a peak at 364 nm. Fourier-Transform Infrared (FTIR) spectroscopy analysis revealed characteristic peaks indicating functional groups involved in nanoparticle formation. Scanning Electron Microscope (SEM) analysis showed spherical/agglomerated nanoparticles, and Energy-Dispersive X-ray Spectroscopy (EDS) confirmed 77.7% zinc oxide by mass%. The X-ray Diffraction (XRD) indicated an average particle size of 24.67 nm with distinct crystal orientations. Phytochemical analysis detected alkaloids, saponins, and steroids in the extract. Optimal synthesis occurred at 50-60°C and pH 10, yielding stable ZnONPs. The ZnONPs exhibited significant antibacterial activity against Staphylococcus aureus (S. aureus), Bacillus subtilis (B. subtilis), Bacillus cereus (B. cereus), Escherichia coli (E.coli), Zymomonas mobilis (Z. mobilis), and Pseudomonas aeruginosa (P. aeruginosa), as well as antifungal activity against Candida albicans (C. albicans). The in vitro cytotoxicity study on M.D. Anderson - Metastatic Breast - 231 (MDA-MB-231) breast cancer cells showed a dose-dependent reduction in cell viability [Half-maximal Inhibitory Concentration (IC50) = 82.13 µg/mL] with notable morphological changes at higher concentrations. The ZnONPs synthesized from ginger peel extract are innovative, environmentally friendly, and economical. Our findings show that biologically generated ZnONPs are effective antibacterial and antifungal agents against several pathogens. This research uniquely demonstrates the potential of ginger peel, a commonly discarded agro-waste, as a sustainable source for ZnONPs synthesis, highlighting its biotechnological and medicinal applications. The novelty of this study lies in the green synthesis approach using ginger peel and the comprehensive evaluation of its antimicrobial and anticancer properties. Further in-depth studies and optimization are needed to validate their therapeutic efficacy and safety.
Chronic obstructive pulmonary disease (COPD) is a progressive respiratory condition, contributing significantly to global morbidity and mortality. Traditional diagnostic tools are effective in diagnosing COPD. However, these tools demand specialized equipment and expertise. Advances in artificial intelligence (AI) provide a platform for enhancing COPD diagnosis by leveraging diverse data modalities. The existing reviews primarily focus on single modalities and lack information on interpretability and explainability. Thus, this review intends to synthesize the AI-powered frameworks for COPD identification, focusing on data modalities, methodological innovation, evaluation strategies, and reporting limitations and potential biases. By adhering to Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, a systematic search was conducted across multiple repositories. From an initial pool of 1978 records, 22 studies were included in this review. The included studies demonstrated exceptional performance in specific settings. Most studies were retrospective and limited in diversity, lacking generalizability and external or prospective validation. This review presents a roadmap for advancing AI-assisted COPD detection. By highlighting the strengths and limitations of existing studies, it supports the development of future research. Future studies can utilize the findings to build models using prospective, multicenter, and multi-ethnic validations, ensuring generalizability and fairness.
INTRODUCTION: Epidermal Growth Factor Receptor (EGFR) is a well-established therapeutic target in cancer treatment. In this study, a novel N-phenylacetamide derivative of theobromine, designated as T-1-PA, was designed as a potential semisynthetic EGFR inhibitor. METHOD: The 3D structure, stability, and electronic reactivity of T-1-PA were determined using Density Functional Theory (DFT) analyses. Molecular docking, molecular dynamics (MD) simulations, Molecular Mechanics Generalized Born Surface Area (MM-GBSA), Protein-Ligand Interaction Profiler (PLIP), and Principal Component Analysis of Trajectories (PCAT) were employed to evaluate the binding affinity and inhibitory potential of T-1-PA against EGFR. Computational ADMET profiling was conducted to predict drug-likeness and safety. Subsequently, T-1-PA was semisynthesized and subjected to in vitro biological evaluation. RESULTS: Computational analyses demonstrated a strong binding affinity of T-1-PA to EGFR. The compound exhibited favorable ADMET properties. In vitro assays revealed potent EGFR inhibition with an IC₅₀ of 0.736 ± 0.005 μM. T-1-PA also inhibited the proliferation of HepG2 and MCF7 cancer cell lines with IC₅₀ values of 0.88 ± 0.01 μM and 1.13 ± 0.01 μM, respectively. Flow cytometry analysis indicated induction of apoptosis and G1 phase cell cycle arrest in HepG2 cells. Additionally, T-1-PA significantly impaired HepG2 cell migration and wound-healing capacity. DISCUSSION: The results validate the computational predictions and highlight the anticancer potential of T-1-PA through EGFR inhibition and antiproliferative activity. The compound's favorable pharmacokinetic and safety profiles further support its therapeutic promise. CONCLUSION: T-1-PA is a promising semisynthetic compound with selective antiproliferative activity mediated via EGFR inhibition. These findings encourage further preclinical investigation of T-1-PA as a novel candidate for EGFR-targeted cancer therapy.
A novel sulfamoylphenyl-dihydro-thiadiazole derivative (compound 14) has been designed and synthesized as a dual inhibitor targeting EGFR and human carbonic anhydrases (hCA_IX and hCA_XII). Computational studies, including density functional theory (DFT), molecular docking, and molecular dynamics simulations, confirmed its stability, favorable binding interactions, and reactivity profiles. Compound 14 showed potent inhibition of EGFR (IC₅₀ = 10.12 ± 0.29 nM), hCA_IX and hCA_XII (IC₅₀ = 79 ± 1.2 nM and 58 ± 0.9 nM, respectively). Cytotoxicity assays demonstrated selective activity against cancer cells, with IC₅₀ values of 16.13 µM in MDA-MB-231 and 22.57 µM in MCF-7 cells, compared to 148.32 µM in non-cancerous Vero cells. Compared to acetazolamide, compound 14 exhibited improved selectivity for cancer cells. Apoptosis studies revealed significant cell death in MDA-MB-231 cells, with early and late apoptosis rates of 22.50% and 58.27%, respectively, alongside a marked G1-phase cell cycle arrest (49.10% in treated cells vs. 44.98% in controls). In silico toxicological evaluations indicated a favorable safety profile, with low irritancy and acceptable rat oral LD₅₀ (15.81 mg/kg) and carcinogenic potency (TD₅₀ = 36.95). Compound 14's potent dual inhibition and selective cytotoxicity make it a promising candidate for further optimization and in vivo studies.